IL233166A0 - Programmable cell model for determining cancer treatments - Google Patents

Programmable cell model for determining cancer treatments

Info

Publication number
IL233166A0
IL233166A0 IL233166A IL23316614A IL233166A0 IL 233166 A0 IL233166 A0 IL 233166A0 IL 233166 A IL233166 A IL 233166A IL 23316614 A IL23316614 A IL 23316614A IL 233166 A0 IL233166 A0 IL 233166A0
Authority
IL
Israel
Prior art keywords
cell model
cancer treatments
programmable cell
determining cancer
determining
Prior art date
Application number
IL233166A
Other languages
Hebrew (he)
Original Assignee
Critical Outcome Technologies Inc
Danter Wayne R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA2012/001152 external-priority patent/WO2013086619A1/en
Application filed by Critical Outcome Technologies Inc, Danter Wayne R filed Critical Critical Outcome Technologies Inc
Publication of IL233166A0 publication Critical patent/IL233166A0/en

Links

IL233166A 2012-12-14 2014-06-16 Programmable cell model for determining cancer treatments IL233166A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CA2012/001152 WO2013086619A1 (en) 2011-12-16 2012-12-14 Programmable cell model for determining cancer treatments
US201261576835P 2012-12-16 2012-12-16

Publications (1)

Publication Number Publication Date
IL233166A0 true IL233166A0 (en) 2014-07-31

Family

ID=51484347

Family Applications (1)

Application Number Title Priority Date Filing Date
IL233166A IL233166A0 (en) 2012-12-14 2014-06-16 Programmable cell model for determining cancer treatments

Country Status (1)

Country Link
IL (1) IL233166A0 (en)

Similar Documents

Publication Publication Date Title
IL254716A0 (en) Zinc-lysine complex
HK1250690A1 (en) Methods
HK1213444A1 (en) Cancer treatments
HK1211623A1 (en) Cell lines
ZA201501914B (en) Method for enhancing specific immunotherapies in cancer treatment
HK1208363A1 (en) New methods
EP2856962A4 (en) Energy-using treatment tool
EP2911230A4 (en) Cell
EP2831949A4 (en) Sodium-oxygen cells
EP2831110A4 (en) Anti-emp2 therapy reduces cancer stem cells
GB2507760B (en) Methods
IL239484A0 (en) Agents for eliminating tumour-initiating cells
IL238453A0 (en) Trans-clomiphene for use in cancer therapy
EP2791843A4 (en) Programmable cell model for determining cancer treatments
GB201207305D0 (en) Therapy
GB201208874D0 (en) Methods
EP2856963A4 (en) Energy-using treatment tool
AU349546S (en) Model
GB201204280D0 (en) Methods
IL233166A0 (en) Programmable cell model for determining cancer treatments
GB201208756D0 (en) Methods
GB201218496D0 (en) Cell
GB201215510D0 (en) Therapeutic cell lines
TWM433710U (en) Enclosed pivot
GB201220686D0 (en) Methods